GlassScriptPhysician profile
Christina Li
NPI 1285676270
$3,776.59
in general payments reported to CMS, 2019-2025
17 companies · $1,031 in 2025
The $1,031 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $18.86 · 2022: $725 · 2023: $1,258 · 2024: $458 · 2025: $1,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937 · Travel and Lodging: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,937.33 |
| Travel and Lodging | $809.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,484.09 | 2022-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $636.28 | 2019-2025 | Echelon; Endopath, Echelon Endopath, Linx Reflux Management System |
| Boston Scientific Corporation | $514.71 | 2024-2025 | Spyglass Discover, Overstitch Endoscopic Suturing System, General - Therapies |
| Davol INC. | $433.66 | 2023-2025 | Phasix Mesh |
| Medtronic, INC. | $331.26 | 2024-2025 | Signia, Ligasure |
| Baxter Healthcare | $95.50 | 2019 | |
| Covidien LP | $41.57 | 2019 | |
| Heron Therapeutics, INC. | $36.18 | 2023 | Zynrelef |
| Stryker Corporation | $32.62 | 2022 | |
| Avanos Medical | $32.43 | 2019 | |
| Acell, INC. | $29.16 | 2019-2020 | |
| Lilly USA, LLC | $27.31 | 2024 | Zepbound |
| Novo Nordisk INC | $20.27 | 2023 | Wegovy |
| Cumberland Pharmaceuticals, INC. | $18.22 | 2019 | |
| W. L. Gore & Associates, INC. | $14.91 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $14.71 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Endo Pharmaceuticals INC. | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.